Updated Jul 16, 2026
Sukhatme Mayukh has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $88.23M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | ROIV | Roivant Sciences Ltd. | F — Tax withholding / forfeiture | 46.9K | $35.39 | $1.66M |
| 2026-06-29 | ROIV | Roivant Sciences Ltd. | S — Open-market sale | 500.0K | $34.08 | $17.04M |
| 2026-06-29 | ROIV | Roivant Sciences Ltd. | M — Option exercise | 500.0K | $3.85 | $1.93M |
| 2026-06-29 | ROIV | Roivant Sciences Ltd. | S — Open-market sale | 500.0K | $34.13 | $17.07M |
| 2026-06-29 | ROIV | Roivant Sciences Ltd. | M — Option exercise | 500.0K | $3.85 | $1.93M |
| 2026-04-01 | ROIV | Roivant Sciences Ltd. | F — Tax withholding / forfeiture | 187.5K | $27.70 | $5.19M |
| 2026-04-01 | ROIV | Roivant Sciences Ltd. | F — Tax withholding / forfeiture | 29.8K | $26.41 | $787K |
| 2026-04-01 | ROIV | Roivant Sciences Ltd. | M — Option exercise | 58.4K | — | |
| 2026-02-11 | ROIV | Roivant Sciences Ltd. | J — Other acquisition / disposition | 312.1K | $26.47 | $8.26M |
| 2026-02-11 | ROIV | Roivant Sciences Ltd. | S — Open-market sale | 339.4K | $26.47 | $8.99M |
| 2026-02-11 | ROIV | Roivant Sciences Ltd. | M — Option exercise | 651.6K | $12.68 | $8.26M |
| 2026-01-01 | ROIV | Roivant Sciences Ltd. | J — Other acquisition / disposition | 1.43M | $21.71 | $31.06M |
| 2026-01-01 | ROIV | Roivant Sciences Ltd. | S — Open-market sale | 1.02M | $21.71 | $22.12M |
| 2026-01-01 | ROIV | Roivant Sciences Ltd. | M — Option exercise | 2.45M | $12.68 | $31.06M |
| 2026-01-01 | ROIV | Roivant Sciences Ltd. | J — Other acquisition / disposition | 436.5K | $21.74 | $9.49M |
| 2026-01-01 | ROIV | Roivant Sciences Ltd. | S — Open-market sale | 311.9K | $21.74 | $6.78M |
| 2026-01-01 | ROIV | Roivant Sciences Ltd. | M — Option exercise | 748.4K | $12.68 | $9.49M |
| 2025-12-20 | ROIV | Roivant Sciences Ltd. | J — Other acquisition / disposition | 32.7K | $23.09 | $755K |
| 2025-12-20 | ROIV | Roivant Sciences Ltd. | S — Open-market sale | 26.8K | $23.09 | $620K |
| 2025-12-20 | ROIV | Roivant Sciences Ltd. | M — Option exercise | 59.5K | $12.68 | $755K |
Sukhatme Mayukh is a corporate insider — currently tracked as President & CIO, Director of Roivant Sciences Ltd. (ROIV). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 10 open-market sales ($88.23M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Sukhatme Mayukh profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.